Press Release - Company Data

Paladin Labs Completes Arrangement
Posted 2014-02-27 23:58NAI Editing
a leading Canadian specialty pharmaceutical company, is pleased to announce the completion of the indirect acquisition by Endo International plc ("New Endo") of all of the outstanding shares of the Co

Paladin Labs Announces Investment Canada Act Approval and South African Competition Act Clearance
Posted 2014-02-17 23:34NAI Editing
a leading Canadian specialty pharmaceutical company, is pleased to inform its shareholders that it has received Investment Canada Act approval and the South African Competition Act clearance in connec

Paladin Labs Announces Independent Proxy Advisory Support for the Endo Health Solutions Inc. Arrangement
Posted 2014-02-10 01:07NAI Editing
a leading Canadian specialty pharmaceutical company, is pleased to inform its shareholders that two leading independent proxy advisory research firms, Institutional Shareholder Services ("ISS") and Gl

Paladin Labs Files Management Information Circular for Special Meeting of Shareholders
Posted 2014-01-23 23:46NAI Editing
a leading Canadian specialty pharmaceutical company, today announced that it has filed its management information circular (the "Information Circular") with the Canadian securities commissions in conn

Paladin Labs Obtains Interim Order for Plan of Arrangement
Posted 2014-01-17 00:13NAI Editing
a leading Canadian specialty pharmaceutical company, today announced that it has obtained an interim order from the Superior Court of Québec (the "Interim Order") in connection with the acquisition of

Paladin Labs Inc.: Endo Health Solutions Files Draft Proxy Statements/Prospectus
Posted 2013-12-10 23:37NAI Editing
today announced that, in connection with the transaction announced on November 5, 2013 with Endo Health Solutions (NASDAQ:ENDP), Endo has filed a draft proxy statement/prospectus with the United State

Paladin Labs Reports Record Third Quarter 2013 Results
Posted 2013-11-13 23:50NAI Editing
a leading specialty pharmaceutical company, today reported its financial results for the quarter ended September 30, 2013.  2013 Third Quarter Highlights

Paladin Labs Inc. to be Acquired by Endo Health Solutions Inc. for $77 per Share
Posted 2013-11-04 23:50NAI Editing
today announced that it has reached a definitive agreement to be acquired by Endo Health Solutions (NASDAQ:ENDP) ("Endo"), a leading U.S.-based specialty pharmaceutical company, in a stock and cash t

Paladin Announces Increase in Ownership of Litha
Posted 2013-09-02 23:42NAI Editing
today announced that it has acquired a block of 71,608,625 shares in Litha Healthcare Group Limited (JSE:LHG) ("Litha") from the Blackstar Group SE and related entities ("Blackstar") at a price of ZAR

Paladin Labs Reports Second Quarter 2013 Results
Posted 2013-08-13 23:20NAI Editing
a leading specialty pharmaceutical company, today reported its financial results for the quarter ended June 30, 2013. 2013 Second Quarter Highlights Financial